» Articles » PMID: 38237058

Surface Cross-Linking by Macromolecular Tethers Enhances Virus-like Particles' Resilience to Mucosal Stress Factors

Abstract

Virus-like particles (VLPs) are emerging as nanoscaffolds in a variety of biomedical applications including delivery of vaccine antigens and cargo such as mRNA to mucosal surfaces. These soft, colloidal, and proteinaceous structures (capsids) are nevertheless susceptible to mucosal environmental stress factors. We cross-linked multiple capsid surface amino acid residues using homobifunctional polyethylene glycol tethers to improve the persistence and survival of the capsid to model mucosal stressors. Surface cross-linking enhanced the stability of VLPs assembled from phage AP205 coat proteins in low pH (down to pH 4.0) and high protease concentration conditions (namely, in pig and mouse gastric fluids). Additionally, it increased the stiffness of VLPs under local mechanical indentation applied using an atomic force microscopy cantilever tip. Small angle X-ray scattering revealed an increase in capsid diameter after cross-linking and an increase in capsid shell thickness with the length of the PEG cross-linkers. Moreover, surface cross-linking had no effect on the VLPs' mucus translocation and accumulation on the epithelium of 3D human nasal epithelial tissues with mucociliary clearance. Finally, it did not compromise VLPs' function as vaccines in mouse subcutaneous vaccination models. Compared to PEGylation without cross-linking, the stiffness of surface cross-linked VLPs were higher for the same length of the PEG molecule, and also the lifetimes of surface cross-linked VLPs were longer in the gastric fluids. Surface cross-linking using macromolecular tethers, but not simple conjugation of these molecules, thus offers a viable means to enhance the resilience and survival of VLPs for mucosal applications.

Citing Articles

Ferritin Vaccine Platform for Animal and Zoonotic Viruses.

Ahmadivand S, Fux R, Palic D Vaccines (Basel). 2024; 12(10).

PMID: 39460279 PMC: 11511493. DOI: 10.3390/vaccines12101112.


mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends.

Gao Y, Yang L, Li Z, Peng X, Li H Biomark Res. 2024; 12(1):93.

PMID: 39217377 PMC: 11366172. DOI: 10.1186/s40364-024-00644-3.

References
1.
Zeng C, Scott L, Malyutin A, Zandi R, van der Schoot P, Dragnea B . Virus Mechanics under Molecular Crowding. J Phys Chem B. 2021; 125(7):1790-1798. DOI: 10.1021/acs.jpcb.0c10947. View

2.
Jimenez-Zaragoza M, Yubero M, Martin-Forero E, Caston J, Reguera D, Luque D . Biophysical properties of single rotavirus particles account for the functions of protein shells in a multilayered virus. Elife. 2018; 7. PMC: 6133545. DOI: 10.7554/eLife.37295. View

3.
Tariq H, Batool S, Asif S, Ali M, Abbasi B . Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases. Front Microbiol. 2022; 12:790121. PMC: 8761975. DOI: 10.3389/fmicb.2021.790121. View

4.
Chung Y, Cai H, Steinmetz N . Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications. Adv Drug Deliv Rev. 2020; 156:214-235. PMC: 7320870. DOI: 10.1016/j.addr.2020.06.024. View

5.
Luo Z, Zhang B, Qian H, Lu Z, Cui S . Effect of the size of solvent molecules on the single-chain mechanics of poly(ethylene glycol): implications on a novel design of a molecular motor. Nanoscale. 2016; 8(41):17820-17827. DOI: 10.1039/c6nr05863a. View